Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel and Cisplatin Every 2 Weeks in Ovarian Cancer
NCT00964626Phase 2Unknown
- Sponsor
- Russian Academy of Sciences
- Start
- Apr 2009
- Primary completion
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel, cisplatin in ovarian cancer, sponsored by Russian Academy of Sciences. Status: unknown.
02
Drugs
paclitaxelcisplatin
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT00964626.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00964626.